STK11 and Hepatic fibrosis: In the liver context, the use of SUBEs has been used very recently to demonstrate the relevance of Liver Kinase B1 (LKB1) SUMOylation during the progression to Hepatocellular Carcinoma (HCC) highlighting its potential for the assessment of ubiquitinated and SUMOylated proteins in liver fibrosis [92].